Cairney, Paul
Published in
International journal of health policy and management
Powell and Mannion suggest that 'health policy process' research should draw more lessons from 'the wider policy process literature.' While health research could continue with sector specific models, the wider literature is 'conceptually stronger.' In that context, I clarify how and why health researchers should use policy theories. I describe a re...
Hoogervorst, Lotje A Geurkink, Timon H Lübbeke, Anne Buccheri, Sergio Schoones, Jan W Torre, Marina Laricchiuta, Paola Piscoi, Paul Pedersen, Alma B Gale, Chris P
...
Published in
International journal of health policy and management
The European Union Medical Device Regulation (MDR) requires manufacturers to undertake post-market clinical follow-up (PMCF) to assess the safety and performance of their devices following approval and Conformité Européenne (CE) marking. The quality and reliability of device registries for this Regulation have not been reported. As part of the Coor...
Beckers, Ruth Hoydonck, Pascale Van
Published in
International journal of health policy and management
The increasing use in clinical practice of software such as mobile apps and clinical decision support (CDS) software has only recently been taken up by regulators around the world. Specifically, the European Commission and the US Food and Drug Administration (FDA) have updated their regulatory framework in the last years. Van Laere et al have given...
Pattanshetty, Sanjay Pardesi, Mantej Gudi, Nachiket
Published in
International journal of health policy and management
The coronavirus disease 2019 (COVID-19) pandemic has coerced various resources of all the countries. While the high-income nations redirected financial and human resources to understand specific determinants of vaccination coverage, fragile and conflict-affected setting (FCS) nations were waiting for global bodies to cater to their ever-growing nee...
Meurs, Mariska Koutsoumpa, Myria Huisman, Valeria
Published in
International journal of health policy and management
The authors wholeheartedly agree with Labonté: global health equity needs radical changes in economic thinking and policies, including degrowth and reducing consumption in parts of the world. But to mobilize sufficient people for radical change, reducing overconsumption and for degrowth, we may need to stop calling it that. Language is important an...
Herrero, María Belén de Oliveira, Beatriz Nascimento Lins
Published in
International journal of health policy and management
The article seeks to shed light on the role of regional organizations in strengthening health research systems in Africa, how they operate and how they work, as well as debts and future challenges. As can be observed also in South America, the continued strengthening of health research requires strategic thinking about the roles, comparative advant...
Kapilashrami, Anuj
Published in
International journal of health policy and management
Lassa and colleagues' study is a strong commentary on the biomedical hegemony and professional monopoly of medical doctors in the policy landscape of the Global Fund in Nigeria. Situating this critical dimension of professional power within wider scholarship of power and governance of global health initiatives (such as the Global Fund), in this com...
Van Laere, Sven Muylle, Katoo M Cornu, Pieter
Published in
International journal of health policy and management
Martens, Monika Xin Chen, Hilario Lorenzo van Olmen, Josefien
Published in
International journal of health policy and management
In their 2021 paper, Palm and Persson Fischier focus on the enabling factors that can facilitate innovation implementation, specifically the step of moving from idea generation to implementation in a healthcare context. The authors address the lack of concretisation of theoretical perspectives related to the implementation of innovations and hence ...
Ozieranski, Piotr Martinon, Luc Jachiet, Pierre-Alain Mulinari, Shai
Published in
International journal of health policy and management
Creating new therapies often involves drug companies paying healthcare professionals and institutions for research and development (R&D) activities, including clinical trials. However, industry sponsorship can create conflicts of interest (COIs). We analysed approaches to drug company R&D payment disclosure in European countries and the distributio...
